Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04529915
Status:
UNKNOWN
Last Update Posted:
2021-12-30
First Post:
2020-08-02
Brief Title:
Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome
Sponsor:
Korea University Guro Hospital
Organization:
Korea University Guro Hospital
Study Overview
Official Title:
Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma
Status:
UNKNOWN
Status Verified Date:
2021-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lung cancer is a leading cause of cancer death worldwide Early diagnosis is linked to a better prognosis Further surgical resection at the early stages of non-small cell lung cancer NSCLC results in markedly improved survival rates Computed tomography CT- or bronchoscopy-guided needle biopsies are standard definitive diagnostic procedures for lung cancer and are used to obtain tissue for pathological examination However these procedures are invasive difficult to repeat expensive and risk exposure to radiation Conversely liquid biopsies such as circulating tumor cells CTCs circulating tumor DNA ctDNA and extracellular vesicles EVs are simple and less invasive procedures that can be repeated more frequently than tissue biopsies
To analyze the exosomes abundantly present in the blood and to conduct clinical studies to determine whether it is possible to diagnose lung cancer To this end blood samples from normal people n 150 and lung cancer patients n 320 are obtained from the Human biobank of five hospitals participating in the study
To analyze the exosomes abundantly present in the blood and to conduct clinical studies to determine whether it is possible to diagnose lung cancer To this end blood samples from normal people n 150 and lung cancer patients n 320 are obtained from the Human biobank of five hospitals participating in the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None